The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre

Bibliographic Details
Main Authors:	Shrimanker, R, Thulborn, S, Mistry, V, Connolly, C, Borg, C, Hargadon, B, Hambleton, K, Hynes, G, Brightling, C, Pavord, I, Bafadhel, M
Format:	Conference item
Published:	American Thoracic Society 2017

Similar Items

Sputum Il-17a levels correlate with biomarkers of non-eosinophilic inflammation in patients with asthma
by: Hynes, G, et al.
Published: (2017)

Eosinophils in asthma and airway hyperresponsiveness.
by: Brightling, C, et al.
Published: (2004)

Characterising non-eosinophilic COPD
by: Hambleton, K, et al.
Published: (2015)

Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?
by: Hambleton, K, et al.
Published: (2016)

The significance of eosinophilic airway inflammation in asthma
by: Pavord, I, et al.
Published: (2002)

Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects
by: Hambleton, K, et al.
Published: (2017)

Case series of long-term macrolide therapy effect on eosinophil count in COPD
by: Asciak, R, et al.
Published: (2017)

Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma
by: Shrimanker, R, et al.
Published: (2018)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
by: Brightling, C, et al.
Published: (2003)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
by: Green, R, et al.
Published: (2002)

Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma
by: George, L, et al.
Published: (2019)

Does a composite score combining peripheral blood eosinophils (PBE) and exhaled nitric oxide (FeNO) accurately predict a sputum eosinophilia?
by: Connolly, CM, et al.
Published: (2017)

Seasonality of eosinophilic and non-eosinophilic exacerbations of COPD
by: Barker, R, et al.
Published: (2017)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
by: Siva, R, et al.
Published: (2007)

Eosinophils in Asthma and Airway Hyperresponsiveness [3] (multiple letters)
by: Brightling, C, et al.
Published: (2004)

The effect of oral corticosteroids on circulating type-2 cytokine producing cells in patients with severe eosinophilic asthma
by: Hynes, G, et al.
Published: (2018)

Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
by: Kulkarni, N, et al.
Published: (2010)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
by: Shrimanker, R, et al.
Published: (2017)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
by: Eltboli, O, et al.
Published: (2014)

Association between blood eosinophil count and small airway eosinophils in smokers with and without COPD
by: Tomoki Maetani, et al.
Published: (2023-10-01)

Investigating blood eosinophil count thresholds in patients with COPD
by: Russell, R, et al.
Published: (2018)

Eosinophils in COPD: just another biomarker?
by: Bafadhel, M, et al.
Published: (2017)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
by: Haldar, P, et al.
Published: (2009)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
by: Moran, AM, et al.
Published: (2020)

Non-eosinophilic corticosteroid unresponsive asthma.
by: Pavord, I, et al.
Published: (1999)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
by: Bafadhel, M, et al.
Published: (2014)

A novel CT scoring system differentiates admissions secondary to eosinophilic from non-eosinophilic asthma
by: Hynes, G, et al.
Published: (2017)

Current smoking reduces small airway eosinophil counts in COPD
by: Augusta Beech, et al.
Published: (2024-01-01)

Blood eosinophil count and exacerbation risk in patients with COPD.
by: Kerkhof, M, et al.
Published: (2017)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
by: Shrimanker, R, et al.
Published: (2017)

Peripheral blood eosinophil drop-to-drop variation in patients with COPD using near patient testing: a small validation study
by: Jeffers, H, et al.
Published: (2017)

Eosinophils in asthma and other allergic diseases.
by: Wardlaw, A, et al.
Published: (2000)

Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis
by: Shrimanker, R, et al.
Published: (2019)

Management and mechanisms of severe eosinophilic asthma
by: Shrimanker, R
Published: (2020)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
by: Berry, M, et al.
Published: (2007)

The significance of eosinophilic inflammation in COPD
by: Cooper, C, et al.
Published: (2017)

Mepolizumab for eosinophilic COPD
by: Sciurba, F, et al.
Published: (2018)

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
by: Bafadhel, M, et al.
Published: (2016)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
by: Berry, M, et al.
Published: (2005)

Eosinophilic phenotypes of airway disease.
by: Pavord, I
Published: (2013)